Asleh K, Brauer HA, Sullivan A, Lauttia S, et al. Predictive biomarkers for adjuvant capecitabine benefit in early stage triple negative breast cancer in the FinXX clinical trial. Clin Cancer Res 2020 Jan 31. pii: 1078-0432.CCR-19-1945.
PMID: 32005747